Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial is to assess the effect of melatonin on MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis. The main question aim to answer : • Does melatonin affect MDA serum, IL-6, IL-8 levels, ANC, and sepsis score in preterm neonates with sepsis? The participants in the treatment group will receive a single dose of oral melatonin 20 mg, meanwhile those the control group will receive placebo. The researchers will compare MDA serum, IL-6, IL-8 levels, ANC, and sepsis score before and after receiving melatonin, whether there are decreases of MDA serum, IL-6, IL-8 levels, ANC and increase of sepsis score


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06191523
Study type Interventional
Source Universitas Sebelas Maret
Contact
Status Completed
Phase N/A
Start date April 27, 2023
Completion date October 20, 2023

See also
  Status Clinical Trial Phase
Completed NCT03111329 - Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding? N/A
Completed NCT03136172 - Monitoring of Systemic or Organ Perfusion for Preterm Infants
Completed NCT03078335 - Glove-based Care in the NICU to Prevent Late Onset Sepsis N/A
Completed NCT03923543 - Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease
Recruiting NCT05121753 - Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Completed NCT03275090 - The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis Phase 4
Recruiting NCT05604846 - Probiotic Supplementation in Extremely Preterm Infants in Scandinavia N/A
Completed NCT03780712 - Immune Dysfunction in Newborn Sepsis